(Q38995005)

8 September 2017

title

Luteolin alleviates alcoholic liver disease induced by chronic and binge ethanol feeding in mice (English)

1 reference

8 September 2017

main subject

alcoholic liver disease

1 reference

Gaigai Liu

1

1 reference

8 September 2017

Yuxue Zhang

2

1 reference

8 September 2017

Chunchun Liu

3

1 reference

8 September 2017

Daqian Xu

4

1 reference

8 September 2017

Rui Zhang

5

1 reference

8 September 2017

Yuan Cheng

6

1 reference

8 September 2017

Yi Pan

7

1 reference

8 September 2017

Cheng Huang

8

1 reference

8 September 2017

Yan Chen

9

1 reference

8 September 2017

language of work or name

English

0 references

publication date

14 May 2014

1 reference

8 September 2017

1 reference

8 September 2017

volume

144

1 reference

8 September 2017

issue

7

1 reference

8 September 2017

page(s)

1009-1015

1 reference

Alcoholic steatohepatitis

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.193128

Current concepts in the pathogenesis of alcoholic liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.193128

21 January 2018

Alcoholic liver disease.

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.193128

SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.193128

Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.193128

Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.193128

Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP)

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.193128

Differential gene expression and lipid metabolism in fatty liver induced by acute ethanol treatment in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.193128

AMP-activated protein kinase signaling in metabolic regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.193128

AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.193128

Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.193128

The role of AMP-activated protein kinase in the action of ethanol in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.193128

AMP-activated protein kinase suppresses LXR-dependent sterol regulatory element-binding protein-1c transcription in rat hepatoma McA-RH7777 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.193128

Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.193128

Role of AMP-activated protein kinase in mechanism of metformin action

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.193128

Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.193128

AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.193128

Anti-carcinogenic effects of the flavonoid luteolin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.193128

Flavonoids as antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.193128

Luteolin suppresses inflammation-associated gene expression by blocking NF-kappaB and AP-1 activation pathway in mouse alveolar macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.193128

Induction of cancer cell apoptosis by flavonoids is associated with their ability to inhibit fatty acid synthase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.193128

Reduction of lipid accumulation in HepG2 cells by luteolin is associated with activation of AMPK and mitigation of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.193128

Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.193128

Mouse model of chronic and binge ethanol feeding (the NIAAA model)

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.193128

Chronic alcohol intake upregulates hepatic expression of carotenoid cleavage enzymes and PPAR in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.193128

Regulation of glucose homeostasis and lipid metabolism by PPP1R3G-mediated hepatic glycogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.193128

Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.193128

Protein sensors for membrane sterols

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.193128

Role of fatty liver, dietary fatty acid supplements, and obesity in the progression of alcoholic liver disease: introduction and summary of the symposium

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.193128

Steatohepatitis: a tale of two "hits"?

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.193128

Liver fibrosis in mice induced by carbon tetrachloride and its reversion by luteolin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3945%2FJN.114.193128

21 January 2018

Identifiers

DOI

10.3945/JN.114.193128

1 reference

8 September 2017

1 reference